Assay Development
Implementing an Electronic Laboratory Notebook (ELN) in pre-clinical drug discovery?
August 29 by Sheraz GulThe pre-clinical phase of drug discovery involves many years of research being conducted by multi-disciplinary teams. These teams will generate significant amounts of data which are processed us...
Increasing Efficiency in Drug Discovery & Development with Aptuit Medicines Research Centre
September 07 by Andrea CharlesIn this podcast Mark Hembarsky, Vice President and Site Leader of the Aptuit Medicines Research Centre in Verona, Italy, and his colleagues Mauro Corsi, Head of Assay Development and In Vitro Profilin...
Assay Development and Immunogenicity Testing
February 25 by Pharma IQImmunogenicity is becoming an integral feature within drug development activities. Testing immunogenicity, however, presents those within the pharmaceutical industry with a host of challenges; ones w...
IQPC Immunogenicity Conference
May 27 by Immunogenicity- IQPCThe FDA has confirmed it will be providing a presentation on the FDA Guidance for Industry White Paper: Ensuring Compliance in Assay Development Immunogenicity Testing. Dr Jennifer Reed, Team Leader,...
The Technological Approach to Immunogenicity
May 11 by Pharma IQWhen it comes to drug development, immunogenicity is one concept that has risen up the agenda for pharmaceutical companies in the past few years. Much investment has been placed into improving the pot...